P

Inventor

DUNCAN KENNETH W

US37 patents
⚠️ This page may combine multiple inventors who share the name “DUNCAN KENNETH W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EPIZYME INC

32 patents
US9365519B2Jun 14, 2016

PRMT5 inhibitors and uses thereof

EPIZYME INC34 citations98
US8993555B2Mar 31, 2015

PRMT5 inhibitors and uses thereof

EPIZYME INC50 citations98
US8940726B2Jan 27, 2015

PRMT5 inhibitors and uses thereof

EPIZYME INC47 citations98
US8906900B2Dec 9, 2014

PRMT5 inhibitors and uses thereof

EPIZYME INC44 citations98
US9855275B2Jan 2, 2018

Aryl-or heteroaryl-substituted benzene compounds

EPIZYME INC18 citations94
US9718816B2Aug 1, 2017

1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof

EPIZYME INC25 citations94
US9611257B2Apr 4, 2017

PRMT5 inhibitors and uses thereof

EPIZYME INC22 citations94
US9604930B2Mar 28, 2017

Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof

EPIZYME INC21 citations94
US9388173B2Jul 12, 2016

PRMT5 inhibitors and uses thereof

EPIZYME INC32 citations94
US9365555B2Jun 14, 2016

PRMT5 inhibitors and uses thereof

EPIZYME INC37 citations94
US9346761B2May 24, 2016

Arginine methyltransferase inhibitors and uses thereof

EPIZYME INC38 citations94
US9266836B2Feb 23, 2016

PRMT5 inhibitors and uses thereof

EPIZYME INC35 citations94
US9221794B2Dec 29, 2015

PRMT5 inhibitors and uses thereof

EPIZYME INC40 citations94
US9908887B2Mar 6, 2018

PRMT5 inhibitors and uses thereof

EPIZYME INC14 citations93
US9777008B2Oct 3, 2017

PRMT5 inhibitors and uses thereof

EPIZYME INC16 citations93
US9765068B2Sep 19, 2017

PRMT5 inhibitors and uses thereof

EPIZYME INC14 citations93
US9745291B2Aug 29, 2017

PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof

EPIZYME INC14 citations93
US9675614B2Jun 13, 2017

PRMT5 inhibitors and uses thereof

EPIZYME INC17 citations93
US10420775B2Sep 24, 2019

Aryl-or heteroaryl-substituted benzene compounds

EPIZYME INC12 citations92
US9732072B2Aug 15, 2017

PRMT5 inhibitors and uses thereof

EPIZYME INC16 citations92
US9732041B2Aug 15, 2017

Arginine methyltransferase inhibitors and uses thereof

EPIZYME INC17 citations92
US11052093B2Jul 6, 2021

Aryl-or heteroaryl-substituted benzene compounds

EPIZYME INC7 citations84
US10391089B2Aug 27, 2019

PRMT5 inhibitors and uses therof

EPIZYME INC5 citations84
US10307413B2Jun 4, 2019

Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof

EPIZYME INC5 citations84
US10150758B2Dec 11, 2018

PRMT5 inhibitors and uses thereof

EPIZYME INC9 citations84
US9776972B2Oct 3, 2017

Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof

EPIZYME INC14 citations84
US12168016B2Dec 17, 2024

Aryl-OR heteroaryl-substituted benzene compounds

EPIZYME INC0 citations73
US12168015B2Dec 17, 2024

Aryl-or heteroaryl-substituted benzene compounds

EPIZYME INC0 citations73
US12161645B2Dec 10, 2024

Aryl-or heteroaryl-substituted benzene compounds

EPIZYME INC0 citations73
US10980794B2Apr 20, 2021

PRMT5 inhibitors and uses thereof

EPIZYME INC1 citations73
US10118918B2Nov 6, 2018

PRMT5 inhibitors and uses thereof

EPIZYME INC2 citations73
US10653693B2May 19, 2020

PRMT5 inhibitors and uses thereof

EPIZYME INC1 citations59

ACCENT THERAPEUTICS INC

3 patents

KUNTZ KEVIN W

1 patent

RAYTHEON CO

1 patent